BeStock  
Stocks › Biotechnology › TRAX

First Tracks Biotherapeutics TRAX

US equityMarket cap rank #2772Biotechnology
$41.64 −$2.82 (-6.34%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $40.70 -2.26%
Open$43.99
Prev close$44.46
Day range$41.23 – $44.74
Volume504.4K
Market cap$1.75B
P/E (TTM)–
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

TRAX at a glance

TRAX is priced at $41.64 right now, down 6.34% on the session. That puts its market value at $1.75B, 2772nd largest among the 3753 stocks we cover.

The stock's 52-week band runs $14.72 to $54.78, and the latest print sits 24.0% under the top end of it.

In the quarter ended Sep 2026 the company brought in $0.00 of revenue, and a net loss of $31.36M.

10 analysts follow the stock and the average call is "buy". The mean target, $75.40, sits 81.1% over where the stock trades.

This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.

Key statistics

Bid / Ask$38.00 / $43.69
Average price today$42.18
Volume504.4KAvg (90d) 795.4K
Turnover$21.27M
Turnover rate1.92%of shares outstanding
Volume ratio0.94vs. recent average pace
Day amplitude7.90%
Market cap$1.75B
Float market cap$1.10B
Shares outstanding26.33M
EPS (TTM)-$4.92
P/B11.59
Book value / share$3.59
Net profit (TTM)-$206.85M
Net assets$151.01M
30-day volatility78.3%annualized
Avg daily range (ATR)7.94%of price, 14 days
Max drawdown (1y)-39.7%-20.4% from 1y peak

Quote as of Nov 20, 2026 8:10 pm ET. Prices can lag the live tape. This is background information, not a recommendation.

BeStock Grade

B
BeStock Grade

Composite of 3 factors below, ranked against the 3734 U.S. stocks BeStock covers.

A
Valuation

Cheaper than usual on its own 5-year P/E history scores higher.

C
Momentum

Trading closer to its 52-week high than most peers scores higher.

B
Wall Street

10 analysts, consensus Buy.

How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.

Six-factor research snapshot

Overall percentile: 78.5 · 2026-11-22 08:27 UTC. Higher values indicate a stronger relative ranking.

FactorPercentile
Valuation—
Growth—
Profitability4.7
Momentum80.5
Financial health98.3
Analyst view87.3

Price forecast

What Wall Street analysts and Morningstar's fair-value model expect for the stock

Analyst price target (avg)$75.40+81.1% vs. current price
Consensus ratingBuy10 analysts covering
Morningstar fair value$44.71Price is below fair value

Wall Street’s average 12-month target is $75.40, 81.1% above today’s price, with a consensus rating of Buy. Morningstar’s fair value model puts the stock at $44.71, so shares trade 6.9% below that estimate. On earnings multiple, it sits in the 5th percentile of its own five-year valuation range (cheaper than usual).

Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.

Performance

Price return over each window, from adjusted daily and weekly closes

1 day
-6.3%
1 week
-11.6%
1 month
-3.5%
3 months
-3.8%
6 months
+142.4%
Day range
$41.23$44.74
52-week range
$14.72$54.78

Technical signals

Full technicals →
Trend readStrong downtrend

1 bullish · 4 bearish of 5 signals

IndicatorValueSignal
Price vs 20-day average-10.2%Bearish
Price vs 50-day average+3.1%Bullish
RSI (14)43.9Bearish
MACD (12,26,9)1.08Bearish
Bollinger band position5%Bearish

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

How TRAX ranks on BeStock

Market value#2760 of 3734
Closeness to 52-week high#1778 of 3724
Dollar volume today#1967 of 3734

Ranks are among the 3,734 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.

TRAX is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.

Since 2020-12-28, the strategy has returned 401.7% (183.6% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated daily — not a guarantee of future results, and not a BeStock recommendation.

Strategy Backtest

Pick a strategy above and run the backtest to see its simulated performance on TRAX.

Rule-based technical strategies computed from this stock’s own price history only. Signals use only data available through the prior trading day (no look-ahead), and trading costs, slippage and taxes aren’t modeled. A backtested rule performing well in the past is not a guarantee of future results — this is an educational illustration, not investment advice.

Community Sentiment on TRAX

No votes yet — be the first to weigh in.

Reader sentiment, not investment advice. One vote per visitor; click again to change it.

TRAX stock: common questions

Where is TRAX trading right now?

$41.64 is the latest print for TRAX, a move of -6.34% against yesterday's close of $44.46. Today's low and high so far: $41.23 and $44.74.

How large is First Tracks Biotherapeutics by market value?

Equity value comes to $1.75B at the current price. By that measure it is number 2772 of the 3753 names in our coverage.

Is TRAX near its 52-week high or low?

The year's floor is $14.72 and the ceiling $54.78. Shares are 24.0% away from that ceiling.

Does First Tracks Biotherapeutics pay a dividend?

Our data shows no dividend paid by First Tracks Biotherapeutics over the trailing twelve months.

Is TRAX rated a buy by Wall Street?

Of 10 analysts, 100% say buy, 0% hold and 0% sell. Price targets average $75.40, with the most cautious at $57.00 and the most optimistic at $110.00.

BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.

Discussion

No comments yet — be the first to weigh in on TRAX.

Sign in to join the discussion.

Scroll to Top